Japan
Rising elderly population boosts Japan's TAVR market
In Japan, TAVR is indicated for patients with severe aortic valve stenosis.
Rising elderly population boosts Japan's TAVR market
In Japan, TAVR is indicated for patients with severe aortic valve stenosis.
BMS wins Marketing & Communications Initiative of the Year - Japan at Healthcare Asia Pharma Awards
It relaunched the Hemapedia website as an innovative, digital platform under an omni-channel strategy.
Japan's liver cancer surveillance program hailed as world's best
The country established the programme for early detection of HCC in the 1980s.
State support boosts Japan's assisted reproductive tech market
The country has the largest market for such devices used for addressing infertility.
Japan's neurology devices market to rebound in five years
The country accounted for a third of the market across Asia Pacific.
Japan's melanoma market urged to ramp up social media activity
Companies were advised to include content providing emotional support for patients.
Digital support for type 2 diabetes patients remain limited
This presents opportunities for digital marketing of T2D therapeutics.
Japan signs deals for vaccine preorders four times the population
The move was lauded as local vaccines remain in Phase II stage.
Fujitsu, Tokyo Shinagawa to develop AI-supported diagnosis of COVID-19 pneumonia
The system is expected to deliver early detection of cases, even when the probablity of infection is low.
COVID-19 dampens Japan's pharma market
Reduced healthcare spending will affect multinationals' capabilities to launch new products.
KMU Hospital orders health tracker ‘Mother'
However, the delivery date is still unknown amid destabilised production.
Challenges plague Asia's health tech assessment programmes
Solutions focus on improving HTAs’ integration to current drug pricing schemes.
MORE Health launches international access to Japan's health services
The partnership with Japan’s Integrity Health will deliver a remote health diagnosis.
Tokyo tops hospital city rankings
It got stellar scores for access and quality of care.
Japanese pharma sales take hit from 'opaque' pricing system
It will grow at a CAGR of 2.3% to $124b in 2023.
Rentschler strengthens Japanese ties with Summit Pharmaceuticals
The East Asian country is the world’s third largest pharmaceuticals market.
Rentschler strengthens Japanese ties with Summit Pharmaceuticals
The East Asian country is the world’s third largest pharmaceuticals market.